{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:04:16Z","timestamp":1792649056873,"version":"4.5.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012504","name":"Royal Melbourne Hospital Neuroscience Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012504","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DP170100363"],"award-info":[{"award-number":["DP170100363"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.neuropharm.2021.108572","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T23:55:46Z","timestamp":1619222146000},"page":"108572","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Effects of antipsychotic drugs and potassium channel modulators on spectral properties of local field potentials in mouse hippocampus and pre-frontal cortex"],"prefix":"10.1016","volume":"191","author":[{"given":"Dechuan","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojtaba","family":"Kermani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5016-735X","authenticated-orcid":false,"given":"Matthew","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjith Rajasekharan","family":"Unnithan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2021.108572_bib1","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1476-5381.1969.tb09527.x","article-title":"Effects of ganglion blocking agents on nicotine extensor convulsions and lethality in mice","volume":"37","author":"Aceto","year":"1969","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108572_bib2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0014-2999(99)00225-3","article-title":"The effect of caffeine in animal models of learning and memory","volume":"373","author":"Angelucci","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108572_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0893-133X(97)00112-7","article-title":"Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence","volume":"18","author":"Arnt","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2021.108572_bib4","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jns.2018.10.004","article-title":"Long-term effects of prolonged-release fampridine in cognitive function, fatigue, mood and quality of life of MS patients: the IGNITE study","volume":"395","author":"Bakirtzis","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2021.108572_bib5","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.neuron.2010.05.013","article-title":"Coherent theta oscillations and reorganization of spike timing in the hippocampal- prefrontal network upon learning","volume":"66","author":"Benchenane","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2021.108572_bib6","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/BF01797193","article-title":"\u00dcber das elektroenkephalogramm des menschen","volume":"87","author":"Berger","year":"1929","journal-title":"Archiv f\u00fcr psychiatrie und nervenkrankheiten"},{"key":"10.1016\/j.neuropharm.2021.108572_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1527-3458.2005.tb00033.x","article-title":"Retigabine: chemical synthesis to clinical application","volume":"11","author":"Blackburn-Munro","year":"2005","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.neuropharm.2021.108572_bib8","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jneumeth.2010.06.020","article-title":"Chronux: a platform for analyzing neural signals","volume":"192","author":"Bokil","year":"2010","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2021.108572_bib9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.schres.2007.11.020","article-title":"The status of spectral EEG abnormality as a diagnostic test for schizophrenia","volume":"99","author":"Boutros","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2021.108572_bib10","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nn.3952","article-title":"What does gamma coherence tell us about inter-regional neural communication?","volume":"18","author":"Buzsaki","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108572_bib11","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41398-019-0471-0","article-title":"Hippocampal-prefrontal coherence mediates working memory and selective attention at distinct frequency bands and provides a causal link between schizophrenia and its risk gene GRIA1","volume":"9","author":"Bygrave","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2021.108572_bib12","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.tics.2010.09.001","article-title":"The functional role of cross-frequency coupling","volume":"14","author":"Canolty","year":"2010","journal-title":"Trends Cognit. Sci."},{"key":"10.1016\/j.neuropharm.2021.108572_bib13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev-neuro-062012-170330","article-title":"Mechanisms and functions of theta rhythms","volume":"36","author":"Colgin","year":"2013","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108572_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1113\/jphysiol.1971.sp009366","article-title":"Prediction of repetitive firing behaviour from voltage clamp data on an isolated neurone soma","volume":"213","author":"Connor","year":"1971","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2021.108572_bib15","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1523\/JNEUROSCI.1774-17.2017","article-title":"Modulation of ether-a-go-go related gene (ERG) current governs intrinsic persistent activity in rodent neocortical pyramidal cells","volume":"38","author":"Cui","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108572_bib16","doi-asserted-by":"crossref","first-page":"e733","DOI":"10.1212\/WNL.0000000000007970","article-title":"Effect of dalfampridine on information processing speed impairment in multiple sclerosis","volume":"93","author":"De Giglio","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2021.108572_bib17","doi-asserted-by":"crossref","first-page":"11609","DOI":"10.1038\/s41598-017-11944-0","article-title":"The antipsychotic drugs olanzapine and haloperidol modify network connectivity and spontaneous activity of neural networks in vitro","volume":"7","author":"Dzyubenko","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2021.108572_bib18","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.neuroscience.2008.10.031","article-title":"N-methyl-d-aspartic acid receptor antagonist-induced frequency oscillations in mice recreate pattern of electrophysiological deficits in schizophrenia","volume":"158","author":"Ehrlichman","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2021.108572_bib19","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1111\/ejn.12015","article-title":"Differential effects of blockade of ERG channels on gamma oscillations and excitability in rat hippocampal slices","volume":"36","author":"Fano","year":"2012","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108572_bib20","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.neuron.2015.09.034","article-title":"Rhythms for cognition: communication through coherence","volume":"88","author":"Fries","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2021.108572_bib21","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/schbul\/sbu170","article-title":"Treatments of negative symptoms in schizophrenia: meta-analysis of 168 randomized placebo-controlled trials","volume":"41","author":"Fusar-Poli","year":"2015","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2021.108572_bib22","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1152\/jn.00400.2006","article-title":"Acute clozapine suppresses synchronized pyramidal synaptic network activity by increasing inhibition in the ferret prefrontal cortex","volume":"97","author":"Gao","year":"2007","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2021.108572_bib23","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nmeth.1694","article-title":"Miniaturized integration of a fluorescence microscope","volume":"8","author":"Ghosh","year":"2011","journal-title":"Nat. Methods"},{"key":"10.1016\/j.neuropharm.2021.108572_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0166-4328(98)00157-0","article-title":"Nicotine enhancement of contextual fear conditioning","volume":"102","author":"Gould","year":"1999","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2021.108572_bib25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.brainres.2004.02.008","article-title":"Effect of 4-aminopyridine on synaptic transmission in rat hippocampal slices","volume":"1006","author":"Gu","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2021.108572_bib26","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neulet.2014.03.025","article-title":"Metabotropic glutamate receptors regulate cortical gamma hyperactivities elicited by ketamine in rats","volume":"567","author":"Hiyoshi","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2021.108572_bib27","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1113\/jphysiol.1952.sp004764","article-title":"A quantitative description of membrane current and its application to conduction and excitation in nerve","volume":"117","author":"Hodgkin","year":"1952","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2021.108572_bib28","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/npp.2009.168","article-title":"Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine","volume":"35","author":"Hong","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2021.108572_bib29","doi-asserted-by":"crossref","first-page":"e784","DOI":"10.1038\/tp.2016.51","article-title":"Reversal of evoked gamma oscillation deficits is predictive of antipsychotic activity with a unique profile for clozapine","volume":"6","author":"Hudson","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2021.108572_bib30","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nm.1962","article-title":"A primate-specific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophrenia","volume":"15","author":"Huffaker","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2021.108572_bib31","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3389\/fgene.2013.00076","article-title":"Major channels involved in neuropsychiatric disorders and therapeutic perspectives","volume":"4","author":"Imbrici","year":"2013","journal-title":"Front. Genet."},{"key":"10.1016\/j.neuropharm.2021.108572_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yebeh.2019.02.005","article-title":"EEG changes in patients on antipsychotic therapy: a systematic review","volume":"95","author":"Jackson","year":"2019","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neuropharm.2021.108572_bib33","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1038\/s41386-020-0697-9","article-title":"A roadmap for development of neuro-oscillations as translational biomarkers for treatment development in neuropsychopharmacology","volume":"45","author":"Javitt","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2021.108572_bib34","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.tics.2007.05.003","article-title":"Cross-frequency coupling between neuronal oscillations","volume":"11","author":"Jensen","year":"2007","journal-title":"Trends Cognit. Sci."},{"key":"10.1016\/j.neuropharm.2021.108572_bib35","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1113\/jphysiol.2014.279083","article-title":"5-Hydroxytryptamine1A receptor-activation hyperpolarizes pyramidal cells and suppresses hippocampal gamma oscillations via Kir3 channel activation","volume":"592","author":"Johnston","year":"2014","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2021.108572_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0030402","article-title":"Theta rhythms coordinate hippocampal-prefrontal interactions in a spatial memory task","volume":"3","author":"Jones","year":"2005","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neuropharm.2021.108572_bib37","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1017\/S1461145711000848","article-title":"Acute administration of typical and atypical antipsychotics reduces EEG gamma power, but only the preclinical compound LY379268 reduces the ketamine-induced rise in gamma power","volume":"15","author":"Jones","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2021.108572_bib38","doi-asserted-by":"crossref","first-page":"8829","DOI":"10.1523\/JNEUROSCI.5176-14.2015","article-title":"Potent KCNQ2\/3-specific channel activator suppresses in vivo epileptic activity and prevents the development of tinnitus","volume":"35","author":"Kalappa","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108572_bib39","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1111\/bph.12710","article-title":"Sex differences in animal models of psychiatric disorders","volume":"171","author":"Kokras","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108572_bib40","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0014-2999(02)02074-5","article-title":"A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs","volume":"450","author":"Kongsamut","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108572_bib41","doi-asserted-by":"crossref","first-page":"13353","DOI":"10.1523\/JNEUROSCI.1463-09.2009","article-title":"Kv7\/KCNQ channels control action potential phasing of pyramidal neurons during hippocampal gamma oscillations in vitro","volume":"29","author":"Leao","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108572_bib42","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0165-0173(02)00220-5","article-title":"Synchronous gamma activity: a review and contribution to an integrative neuroscience model of schizophrenia","volume":"41","author":"Lee","year":"2003","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.neuropharm.2021.108572_bib43","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","article-title":"Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis","volume":"373","author":"Leucht","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2021.108572_bib44","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1038\/mp.2017.249","article-title":"Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention","volume":"23","author":"Lieberman","year":"2018","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2021.108572_bib45","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.neuron.2013.03.007","article-title":"The theta-gamma neural code","volume":"77","author":"Lisman","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2021.108572_bib46","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0006-3495(99)77236-X","article-title":"Analysis of dynamic brain imaging data","volume":"76","author":"Mitra","year":"1999","journal-title":"Biophys. J."},{"key":"10.1016\/j.neuropharm.2021.108572_bib47","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/pcn.12301","article-title":"Evaluation of resting state gamma power as a response marker in schizophrenia","volume":"69","author":"Mitra","year":"2015","journal-title":"Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108572_bib48","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/schbul\/sbr056","article-title":"High vs low frequency neural oscillations in schizophrenia","volume":"37","author":"Moran","year":"2011","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2021.108572_bib49","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1600-0447.1985.tb05055.x","article-title":"Prefrontal cortex dysfunction as a common factor in psychosis","volume":"71","author":"Muller","year":"1985","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.neuropharm.2021.108572_bib50","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1111\/j.1476-5381.1995.tb17214.x","article-title":"Characterization of inhibition by haloperidol and chlorpromazine of a voltage-activated K+ current in rat phaeochromocytoma cells","volume":"116","author":"Nakazawa","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108572_bib51","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.neuropharm.2011.01.022","article-title":"GABAergic interneuron origin of schizophrenia pathophysiology","volume":"62","author":"Nakazawa","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2021.108572_bib52","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/0006-8993(89)91546-1","article-title":"Psychotropic drugs block voltage-gated ion channels in neuroblastoma cells","volume":"476","author":"Ogata","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2021.108572_bib53","doi-asserted-by":"crossref","first-page":"156869","DOI":"10.1155\/2011\/156869","article-title":"FieldTrip: open source software for advanced analysis of MEG, EEG, and invasive electrophysiological data","volume":"2011","author":"Oostenveld","year":"2011","journal-title":"Comput. Intell. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108572_bib54","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/cne.10886","article-title":"Expression pattern of the ether-a-gogo-related (ERG) K+ channel-encoding genes ERG1, ERG2, and ERG3 in the adult rat central nervous system","volume":"466","author":"Papa","year":"2003","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108572_bib55","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/cercor\/6.6.771","article-title":"Tetraethylammonium-induced synaptic plasticity in rat neocortex","volume":"6","author":"Pelletier","year":"1996","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.neuropharm.2021.108572_bib56","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cardiores.2004.09.030","article-title":"Expression of human ERG K+ channels in the mouse heart exerts anti-arrhythmic activity","volume":"65","author":"Royer","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.neuropharm.2021.108572_bib57","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fnins.2019.00125","article-title":"Cross-frequency coupling based neuromodulation for treating neurological disorders","volume":"13","author":"Salimpour","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108572_bib58","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1523\/JNEUROSCI.04-02-00604.1984","article-title":"A transient potassium conductance regulates the excitability of cultured hippocampal and spinal neurons","volume":"4","author":"Segal","year":"1984","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108572_bib59","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/schbul\/sbm106","article-title":"Ether-a-go-go-related gene potassium channels: what's all the buzz about?","volume":"33","author":"Shepard","year":"2007","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2021.108572_bib60","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuron.2005.02.028","article-title":"Prefrontal phase locking to hippocampal theta oscillations","volume":"46","author":"Siapas","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2021.108572_bib61","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nature08855","article-title":"Impaired hippocampal-prefrontal synchrony in a genetic mouse model of schizophrenia","volume":"464","author":"Sigurdsson","year":"2010","journal-title":"Nature"},{"issue":"Pt 1","key":"10.1016\/j.neuropharm.2021.108572_bib62","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/brain\/123.1.171","article-title":"Effects of 4-aminopyridine on demyelinated axons, synapses and muscle tension","volume":"123","author":"Smith","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2021.108572_bib63","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nature07991","article-title":"Parvalbumin neurons and gamma rhythms enhance cortical circuit performance","volume":"459","author":"Sohal","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2021.108572_bib64","doi-asserted-by":"crossref","first-page":"17288","DOI":"10.1073\/pnas.0406074101","article-title":"Neural synchrony indexes disordered perception and cognition in schizophrenia","volume":"101","author":"Spencer","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2021.108572_bib65","doi-asserted-by":"crossref","first-page":"35080","DOI":"10.1038\/srep35080","article-title":"The anticonvulsant retigabine suppresses neuronal KV2-mediated currents","volume":"6","author":"Stas","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2021.108572_bib66","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1523\/JNEUROSCI.21-15-05535.2001","article-title":"Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine","volume":"21","author":"Tatulian","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108572_bib67","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1152\/jn.00106.2010","article-title":"Measuring phase-amplitude coupling between neuronal oscillations of different frequencies","volume":"104","author":"Tort","year":"2010","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2021.108572_bib68","doi-asserted-by":"crossref","first-page":"20942","DOI":"10.1073\/pnas.0911331106","article-title":"Theta-gamma coupling increases during the learning of item-context associations","volume":"106","author":"Tort","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2021.108572_bib69","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.biopsych.2014.11.019","article-title":"Oscillations and neuronal dynamics in schizophrenia: the search for basic symptoms and translational opportunities","volume":"77","author":"Uhlhaas","year":"2015","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2021.108572_bib70","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1152\/physrev.00036.2011","article-title":"hERG K(+) channels: structure, function, and clinical significance","volume":"92","author":"Vandenberg","year":"2012","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2021.108572_bib71","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/schbul\/sbn021","article-title":"Genetic and disorder-specific aspects of resting state EEG abnormalities in schizophrenia","volume":"35","author":"Venables","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2021.108572_bib72","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1152\/physrev.00035.2008","article-title":"Neurophysiological and computational principles of cortical rhythms in cognition","volume":"90","author":"Wang","year":"2010","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2021.108572_bib73","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1523\/JNEUROSCI.0098-05.2005","article-title":"Potassium channel blockers inhibit the triggers of attacks in the calcium channel mouse mutant tottering","volume":"25","author":"Weisz","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108572_bib74","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fncel.2015.00089","article-title":"Differential modulation of repetitive firing and synchronous network activity in neocortical interneurons by inhibition of A-type K(+) channels and Ih","volume":"9","author":"Williams","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108572_bib75","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0006-3495(80)85034-X","article-title":"Inhibition of potassium conductance with external tetraethylammonium ion in Myxicola giant axons","volume":"32","author":"Wong","year":"1980","journal-title":"Biophys. J."},{"key":"10.1016\/j.neuropharm.2021.108572_bib76","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/01.RES.80.2.261","article-title":"Tissue and species distribution of mRNA for the IKr-like K+ channel, erg","volume":"80","author":"Wymore","year":"1997","journal-title":"Circ. Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082100126X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082100126X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:10:33Z","timestamp":1758438633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839082100126X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":76,"alternative-id":["S002839082100126X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108572","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.05.26.116343","asserted-by":"object"}]},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of antipsychotic drugs and potassium channel modulators on spectral properties of local field potentials in mouse hippocampus and pre-frontal cortex","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108572","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108572"}}